GCM
BHC icon

Ghisallo Capital Management’s Bausch Health BHC Stock Holding History

Ghisallo Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-400,000
Closed -$9.14M – 274
2022
Q1 		$9.14M Buy
+400,000
New +$9.78M 0.99% 9

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Ghisallo Capital Management's BHC Position: Q2 2022 in Review

Ghisallo Capital Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 400,000 shares — an estimated $9.14M sold.

Ghisallo Capital Management first reported a position in BHC in Q1 2022 and held it in 1 quarter. The position peaked at $9.14M in Q1 2022. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Ghisallo Capital Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Ghisallo Capital Management sold 400,000 Bausch Health shares in Q2 2022, an estimated $9.14M.
  • Ghisallo Capital Management first reported a position in Bausch Health in Q1 2022 and held it in 1 quarter.
  • Ghisallo Capital Management's Bausch Health position peaked at $9.14M in Q1 2022.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Ghisallo Capital Management's 13F filing for Q2 2022, filed 9 Aug 2022.